Rare pulmonary diseases: a common fight

Sergio Harari, Marc Humbert

Source: Eur Respir Rev, 26 (145) 170059; 10.1183/16000617.0059-2017
Journal Issue: September

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sergio Harari, Marc Humbert. Rare pulmonary diseases: a common fight. Eur Respir Rev, 26 (145) 170059; 10.1183/16000617.0059-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension: a paradigm for rare pulmonary diseases
Source: Eur Respir Rev, 26 (146) 170120; 10.1183/16000617.0120-2017
Year: 2017



Immundefects, rare pulmonary infections and rare lung diseases
Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases
Year: 2020


Rare pulmonary disease and orphan drugs: a path to the future
Source: Eur Respir Rev, 28 (153) 190115; 10.1183/16000617.0115-2019
Year: 2019



Pulmonary diseases and ageing
Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine
Year: 2020


Rare lung diseases in children: challenges for diagnosis and treatment
Source: Virtual Congress 2021 – Rare lung diseases 2021
Year: 2021


Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
Source: Eur Respir Rev 2015; 24: 375-377
Year: 2015


Orphan ILD: a spectrum of rare and/or neglected diseases
Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases
Year: 2008


Rare and orphan lung diseases
Source: ISSN=ISSN 1810-6838, ISBN=, page=146
Year: 2005

Toward better management of rare and orphan pulmonary diseases
Source: Eur Respir J 2016; 47:1334-1335
Year: 2016


Candidosis due to treatment pulmonary diseases
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009

Pulmonary hydatid disease: a unique treatment for an uncommon disease
Source: Eur Respir J 2007; 30: Suppl. 51, 392s
Year: 2007

Severe pulmonary infections due to biological therapy of rheumatic diseases
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011


Sarcoidosis: an underrecognised cause for bullous lung disease?
Source: Eur Respir J 2009; 34: 999-1001
Year: 2009


Infections in children: is there an underlying rare disease?
Source: International Congress 2019 – Part I: Prevention and management of respiratory infections in primary care.
Year: 2019


Development of medicines for rare diseases: where are the problems?
Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases"
Year: 2014

Idiopathic pulmonary fibrosis: a treatable disease?
Source: Eur Respir J 2003 Dec 01;22(6):872-873
Year: 2003


Epidemiology: why is pleural disease becoming more common?
Source: Eur Respir Monogr 2020; 87: 1-12
Year: 2020


Whipple’s disease: a rare and life-threatening cause of pulmonary hypertension
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis
Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020
Year: 2021